Treatment of refractory immune cytopenias in the 21st Century - How safe is rituximab? [8]

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 92-93

  Ravindranath, Yaddanapudi ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; FLUDARABINE; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB; STEROID; VINCRISTINE;

ANAPHYLAXIS; AUTOIMMUNE HEMOLYTIC ANEMIA; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CAUSE OF DEATH; CHICKENPOX; CHRONIC MYELOID LEUKEMIA; COLD ANTIBODY IMMUNE HEMOLYTIC ANEMIA; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DISEASE COURSE; DRUG FATALITY; DRUG SAFETY; HEPATITIS; HEPATITIS B; HUMAN; LARGE CELL LYMPHOMA; LETTER; LYMPHATIC LEUKEMIA; PLASMAPHERESIS; PRIORITY JOURNAL; REFRACTORY IMMMUNE CYTOPENIA; T CELL DEPLETION; TREATMENT OUTCOME;

AGED; ANEMIA; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOLOGIC FACTORS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE DEPLETION; MIDDLE AGED; SAFETY;

EID: 24344492728     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20464     Document Type: Letter

References (5)

1. Qazilbash M. Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia. Am J Hematol 2005 (in press).
2. Özgönenel BS, et al. Fulminant hepatitis b following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma. Am J Hematol (submitted).
3. Bader-Meunier B, Gabolde M, Casadevall N, Seguin G, Tchernia G. Life-threatening complication of Rituximab in a child. Haematologica 2002;87:ECR45.
4. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 2000;96:1184-1186.
5. Suzan F, Ammor M, Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med 2001;345:1000.